ASO, allele-specific oligonucleotides; CMV, cytomegalovirus; Flow, flow cytometry; IV, intravenous; N, number; N/A, not available; PCR, polymerase chain reaction.

*Median 4 weeks;

**median 9 weeks;

^†treatment study